Please try another search
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chinese medicine anti-inflammatory products. The company was founded in 1997 and is based in Xi'an, China.
Name | Age | Since | Title |
---|---|---|---|
Leipeng Jiao | 40 | 2019 | Independent Director |
Xiaofeng Xie | 48 | 2013 | Non-Independent Director |
Haiyun Ren | 50 | 2019 | Independent Director |
Shuiping Zhang | 59 | - | Non-Independent Director |
Wenfeng Zhu | 54 | 2022 | Shareholder Supervisor |
Qingshui Luo | 63 | - | Chairman of the Supervisory Board & Director of Legal Department |
Tailin Xiong | 48 | 2022 | Employee Representative Supervisor |
Xiaofeng Niu | 58 | 2022 | Independent Director |
Zhekun Chen | 42 | - | Supervisor |
Hui Ma | 41 | 2022 | Shareholder Supervisor |
Zhihong Zhang | 60 | - | Deputy GM & Director |
Jie Wu | 54 | - | Deputy GM, Board Secretary & Director |
Dezhu Zhang | 48 | 2023 | Deputy & GM Director |
Xiaolin Xie | 56 | - | GM & Chairman |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review